GlobeNewswire
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia
📈
AI Sentiment
Highly Positive
8/10
Addex Therapeutics Ltd News
Latest updates and market news for ADXN
1 news
Jan 6 - Jan 12, 2026
Page 1
Share this news page